Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience

202047 citationsJournal Articlehybrid Open Access

Authors

Lewis Kass-Iliyya · Sheffield Teaching Hospitals NHS Foundation Trust

John A. Snowden · University of Sheffield

Alice Thorpe · Sheffield Teaching Hospitals NHS Foundation Trust

Helen Jessop · Sheffield Teaching Hospitals NHS Foundation Trust

Andrew Chantry · Sheffield Teaching Hospitals NHS Foundation Trust

Ptolemaios G. Sarrigiannis · Sheffield Teaching Hospitals NHS Foundation Trust

Abstract

Auto-HSCT is an intensive but well tolerated and effective treatment option for patients with SPS refractory to conventional immunotherapy. Further work is warranted to optimise patient selection and establish the efficacy, long-term safety, and cost-effectiveness of this treatment.

Topics & Keywords

Autoimmune Neurological Disorders and Treatments Neurological disorders and treatments Long-Term Effects of COVID-19

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Neurology

Volume 268, Issue 1, pp. 265-275

DOI: 10.1007/s00415-020-10054-8

Field-Weighted Citation Impact: 2.25